Skip to content

PTSD and Cannabis

PTSD and Cannabis

Post-Traumatic Stress Disorder (PTSD) is a psychiatric disorder that occurs in people who witnessed or have gone through a traumatic event.  That can include events such as  natural disasters, war/combat, a serious accident, or personal assault, among others.  People suffering from PTSD have disturbing thoughts and feelings related to the traumatic event that can last months or even years. 

According to the National Center for PTSD,

  • About 7 or 8 out of every 100 people (or 7-8% of the population) will have PTSD at some point in their lives.
  • About 8 million adults have PTSD during a given year. This is only a small portion of those who have gone through a trauma.
  • About 10 of every 100 women (or 10%) develop PTSD sometime in their lives compared with about 4 of every 100 men (or 4%). Learn more about women, trauma and PTSD.

As more research has been conducted on the benefits of cannabis and the endocannabinoid system, we at Arfinn Med would like to share some of the current research regarding medical marijuana and the treatment of PTSD.

An article written by healthcareinamerica.us explains how cannabinoids such as THC and CBD can help patients suffering from PTSD:

“CBD and THC are capable of helping treat people suffering from PTSD by improving the endocannabinoid system’s mediation of essential functions including memory consolidation and retrieval. By activating CB1 and CB2 receptors located throughout this core system, cannabinoids could prompt the system to produce neurotransmitters that helps promote happiness, pleasure, and memory. These cannabinoids play a critical role in assisting PTSD cases by preventing the retrieval of the underlying trauma, effectively preventing traumatic memories and nightmares, while also helping attain emotional wellbeing. This has made it a popular treatment for PTSD patients, of which many are combat veterans.”

The article goes on to mention a research study conducted by NYU Langone Medical Center that found, “people suffering from PTSD have much lower levels of a neurotransmitter called anandamide than others. Anandamide is one of the body’s primary endocannabinoids, meaning natural cannabinoids produced by the body. These operate in a similar way to cannabis by stimulating the endocannabinoid system, which is responsible for core functions such as mood, happiness, fear, and anxiety.”

The state of New Mexico also conducted their own study on patients in their medical marijuana program who were suffering from PTSD.  They found that there was a greater than 75% reduction in CAPS (The Clinician Administered Posttraumatic Scale for DSM-IV) symptom scores reported when patients were using cannabis compared to when they were not.

These studies, along with others concerning cannabis and patients with PTSD have accelerated the call for more research to be conducted. The San Diego VA recently announced that they will be conducting a 1.3 million dollar study on PTSD and cannabis, and more states are adding PTSD to their qualifying conditions list.  

Arfinn Med’s clinical efficacy data on patients with PTSD echoes the above findings with an average efficacy score of 3.9 out of 5, which indicates a significant resolution of symptoms. 

We at Arfinn Med look forward to more research being conducted on medical marijuana as it pertains to treating symptoms of PTSD, and also encourage anyone who wants more information to speak to their doctor to learn if this might be a viable treatment option for them.

References:

https://www.ncbi.nlm.nih.gov/pubmed/24830188

https://www.research.va.gov/currents/0219-San-Diego-VA-study-testing-cannabidiol.cfm

https://healthcareinamerica.us/cannabis-key-treating-ptsd-b4abf432215

https://www.psychiatry.org/patients-families/ptsd/what-is-ptsd

https://www.ptsd.va.gov/understand/common/common_adults.asp

Stories you may be interested in

Are You Prepared For Questions About Medical Cannabis?

With over 85% of Americans supporting legalizing medical cannabis, it’s inevitable that patients will begin asking their primary care doctors about its use and overall efficacy. Doctors and other medical professionals will be called upon to be ‘sense-makers’ for a treatment they never studied in medical school and have limited available research to draw upon. …
Read More

Medical marijuana advocates concerned over recreational cannabis proposals

ALBUQUERQUE, N.M.— Some medical marijuana patients are concerned the proposed framework for legalizing recreational marijuana could have a potentially negative impact on the medical cannabis program. “It’s something that will devastate the medical program in doing so,” said Jason Barker, a medical cannabis advocate with Safe Access New Mexico. A special task force delivered a…
Read More

Medical Marijuana and Cancer

September is dedicated to recognizing numerous cancers that many around the world suffer from, including prostate, thyroid, ovarian and blood cancers. These cancers and many others can produce life-debilitating symptoms and conditions that are difficult to treat with traditional medications. Although there might not be one ‘perfect fix’ when it comes to curing cancer, medical…
Read More

$2.7 million awarded for medical marijuana research in Colorado

The state has awarded $2.7 million for research into how medical marijuana could replace opioids to ease chronic spinal pain — and how it might treat irritability in children and adolescents with autism. Read the full story here.
Read More

Medical marijuana: Florida House seeks to intervene in ‘monumental’ case

TALLAHASSEE — Florida House leaders should be able to participate in a lawsuit that could revolutionize the state’s medical marijuana market, a lawyer for the Republican-led chamber told a three-judge panel of the 1st District Court of Appeal Tuesday. But Tampa-based Florigrown argued that legislators instead should concentrate on fixing the law, aimed at carrying…
Read More

Substance in cannabis ‘could boost pancreatic cancer treatments’

A substance found in cannabis plants might boost treatments for patients with pancreatic cancer, research in mice has suggested. Cannabidiol, or CBD, is not psychoactive, meaning it does not produce feelings of being high in those who take it. It is extracted from hemp plants and is legal in the UK, although a CBD product…
Read More

Leave a Comment

You must be logged in to post a comment.